Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Demetri

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Cancer|February 1, 2007
Markers of angiogenesis and clinical features in patients with sarcomaSteven DuBois, George Demetri
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Cancer|October 29, 2009
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patientsStephen Sonis, Nathaniel Treister, Sant Chawla, et al.
Human Pathology|July 3, 2002
Clinical management of gastrointestinal stromal tumors: before and after STI-571Ronald P Dematteo, Michael C Heinrich, Wa'el M El-Rifai, et al.
The Lancet. Oncology|November 9, 2002
Management of malignant gastrointestinal stromal tumoursHeikki Joensuu, Christopher Fletcher, Sasa Dimitrijevic, et al.
Patient Education and Counseling|October 26, 2005
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regretJo Ellen Stryker, Ricardo J Wray, Karen M Emmons, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 16, 2007
Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectationsRicardo J Wray, Jo Ellen Stryker, Eric Winer, et al.
Seminars in Nephrology|December 19, 2016
Personalized Comments on Challenges and Opportunities in Kidney Disease Therapeutics: The Glom-NExT SymposiumAnna Greka, Deb Gibson, Peter Mundel, et al.
Clinical Drug Investigation|January 16, 2007
Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumoursDaniel M Huse, Margaret von Mehren, Gregory Lenhart, et al.
Oral Oncology|September 6, 2011
Clinical presentation and management of mTOR inhibitor-associated stomatitisMarcio Augusto de Oliveira, Fabiana Martins E Martins, Qian Wang, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Cancer|February 1, 2007
Markers of angiogenesis and clinical features in patients with sarcomaSteven DuBois, George Demetri
Nature Reviews. Drug Discovery|August 11, 2007
Molecular basis for sunitinib efficacy and future clinical developmentSandrine Faivre, George Demetri, William Sargent, et al.
Cancer|October 29, 2009
Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patientsStephen Sonis, Nathaniel Treister, Sant Chawla, et al.
Human Pathology|July 3, 2002
Clinical management of gastrointestinal stromal tumors: before and after STI-571Ronald P Dematteo, Michael C Heinrich, Wa'el M El-Rifai, et al.
The Lancet. Oncology|November 9, 2002
Management of malignant gastrointestinal stromal tumoursHeikki Joensuu, Christopher Fletcher, Sasa Dimitrijevic, et al.
Patient Education and Counseling|October 26, 2005
Understanding the decisions of cancer clinical trial participants to enter research studies: factors associated with informed consent, patient satisfaction, and decisional regretJo Ellen Stryker, Ricardo J Wray, Karen M Emmons, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|June 16, 2007
Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectationsRicardo J Wray, Jo Ellen Stryker, Eric Winer, et al.
Seminars in Nephrology|December 19, 2016
Personalized Comments on Challenges and Opportunities in Kidney Disease Therapeutics: The Glom-NExT SymposiumAnna Greka, Deb Gibson, Peter Mundel, et al.
Clinical Drug Investigation|January 16, 2007
Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumoursDaniel M Huse, Margaret von Mehren, Gregory Lenhart, et al.
Oral Oncology|September 6, 2011
Clinical presentation and management of mTOR inhibitor-associated stomatitisMarcio Augusto de Oliveira, Fabiana Martins E Martins, Qian Wang, et al.
Pageof 3